Pharma & Biotech

Filtration plays a critical role in API production, where crystallization, catalyst removal, and purification steps demand high solids capture and product purity. DrM filtration systems provide closed, automated separation of fine crystals, catalyst residues, or intermediates under GMP-compliant conditions. Their ability to integrate cake washing, drying, and enclosed discharge supports process efficiency while minimizing product loss, contamination risk, and operator exposure. These systems are scalable for both clinical batch production and large-scale manufacturing environments.​

Antibiotic fermentation and purification processes generate slurries rich in biomass, precipitated solids, or resin fines that require precise clarification. DrM filters are used for intermediate separation after biomass removal, during purification steps, or in final polishing. Their hygienic design supports closed operation, filter cake washing, and minimal hold-up volume, all essential for consistency and regulatory compliance. Automated cycles reduce manual handling and help maintain product integrity during downstream processing.​

Vitamin production often involves microbial or chemical synthesis followed by precipitation and purification stages. DrM filtration systems are used to remove reaction byproducts, carbon treatment residues, or crystallized vitamins from solution. The closed system design reduces oxidation risk and supports low-temperature, solvent-compatible processing. Efficient solids capture and gentle handling are particularly important in heat- or pH-sensitive formulations such as Vitamin C or B-complex compounds.​

Production of iodinated or gadolinium-based contrast media involves multi-step synthesis, purification, and removal of insoluble byproducts or catalyst residues. DrM filtration systems provide high-clarity output under sterile or hygienic conditions, supporting consistent product quality and compliance with pharmacopeial standards. Their enclosed operation and optional cake washing reduce contamination risk and improve yield in the final formulation. These systems are suitable for use with both aqueous and organic solvent-based contrast agents.​